Premium
Laboratory and epidemiologic assessment of a recent influenza B outbreak
Author(s) -
King James C.,
Haugh Connor J.,
Dupont William D.,
Thompson Juliette M.,
Wright Peter F.,
Edwards Kathryn M.
Publication year - 1988
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.1890250313
Subject(s) - outbreak , serology , virology , titer , neuraminidase , medicine , influenzavirus b , throat , virus , immunology , orthomyxoviridae , influenza a virus , antibody , anatomy
A viral surveillance system in Nashville detected an outbreak of influenza B that occurred between January and March 1986. Paired sera from 32 individuals with culture‐documented influenza B illness were tested using three serologic assays. Enzyme‐linked immunosorbent assay (ELISA) using purified hemagglutinin‐neuraminidase and plaque neutralization detected a seroresponse in 69% and 66% of these individuals, respectively. These assays were superior to hemagglutination inhibition, which detected a 41% seroresponse. ELISA was preferred because of cost and ease of performance. A group of 286 individuals, aged 1–65 years, was studied more extensively including serologic assessment before and after the influenza B outbreak. Historical information and viral throat cultures were obtained from those with influenza‐like illness during the epidemic. An influenza B infection rate (seroresponse and/or positive culture) of 31% and illness rate (infection with flu‐like symptoms during the epidemic period) of 13% was demonstrated using these methods. Pre‐epidemic mean serum ELISA IgG titers were lower in those with, versus those without, evidence of subsequent influenza B illness (1,541 vs. 4,311, P = .0026). Children ≤ 15 years of age were infected more frequently than adults (44% vs. 28%, P = .04). Fever ≥ 101°F was reported more frequently with influenza B than non‐B illness (43% vs. 18%, P = .03). These data are useful in preparing for future epidemiologic studies of influenza B and demonstrate the value of and need for standardization of ELISA as a serologic assay for influenza B.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom